Exagen Q4 Earnings Call Highlights [Yahoo! Finance]
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Trailing 12-month ASP increased to about (up ~7% from $411), but management reported second-half ASP pressure—largely a transitory impact from a one-time Northwell billing change (~2% of volume, ~ ASP effect) and the ramp of new biomarkers that should ultimately add to ASP (T-cell+RA33 ~ target; anti-PAD4 ~ expected). For 2026 the company guided revenue of $70–73 million and expects high single-digit volume growth and low single-digit ASP growth; management says breakeven Adjusted EBITDA and positive cash generation are reachable near an ~ $80 million run rate, and the balance sheet shows just over $32 million cash with $43 million in cash plus accounts receivable for runway. Interested in Exagen Inc.? Here are five stocks we like better. Exagen (NASDAQ:XGN) executives said the company closed 2025 with record revenue and testing volume, pointing to progress from operational changes made over the past several years, while acknowledging near-term average selling price (ASP) pres
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- Exagen (XGN) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=XGN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "sell".MarketBeat
- Exagen (XGN) had its price target lowered by Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen (XGN) had its price target lowered by Craig Hallum from $12.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen (XGN) had its price target lowered by KeyCorp from $15.00 to $10.00. They now have an "overweight" rating on the stock.MarketBeat
- Avolta AG GAAP EPS of CHF 1.36, revenue of CHF 13.76B [Seeking Alpha]Seeking Alpha
XGN
Earnings
- 3/10/26 - In-Line
XGN
Sec Filings
- 3/16/26 - Form 3
- 3/16/26 - Form 4
- 3/16/26 - Form 4
- XGN's page on the SEC website